Brokerage Radar UBS favors Sun Pharma, Cipla Morgan Stanley sees relief for IT sector - Moneycontrol
| SUNPHARMA | 1,781 46.65 2.69% |
Slightly above 55% of Sun Pharmaceutical's retail investors are presently thinking to get in. The analysis of overall sentiment of trading Sun Pharmaceutical Industries stock suggests that some investors are interested at this time. Sun Pharmaceutical's investing sentiment overview a quick insight into current market opportunities from investing in Sun Pharmaceutical Industries. Many technical investors use Sun Pharmaceutical stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Sun Pharmaceutical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Sun daily returns and investor perception about the current price of Sun Pharmaceutical Industries as well as its diversification or hedging effects on your existing portfolios.
Sun |
Brokerage Radar UBS favors Sun Pharma, Cipla Morgan Stanley sees relief for IT sector Moneycontrol
Read at news.google.com
 |
Sun Pharmaceutical Fundamental Analysis
We analyze Sun Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sun Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sun Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Sun Pharmaceutical is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Sun Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sun Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Sun Pharmaceutical could also be used in its relative valuation, which is a method of valuing Sun Pharmaceutical by comparing valuation metrics with similar companies.
Peers
Sun Pharmaceutical Related Equities
| MRF | MRF | 1.28 | ||||
| BOSCHLTD | Bosch | 0.84 | ||||
| BAJAJHLDNG | Bajaj Holdings | 0.75 | ||||
| VHL | Vardhman Holdings | 0.38 |
Additional Tools for Sun Stock Analysis
When running Sun Pharmaceutical's price analysis, check to measure Sun Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sun Pharmaceutical is operating at the current time. Most of Sun Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sun Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sun Pharmaceutical's price. Additionally, you may evaluate how the addition of Sun Pharmaceutical to your portfolios can decrease your overall portfolio volatility.